Company / SG&A per Share
Krystal Biotech, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$5.10
FY2025
5-year range
$1.82 / $5.10
FY2021-FY2025
Trend
+26.6%
vs FY2024
Sector context
#32 of 210
Health Care
What the data says
Krystal Biotech, Inc.'s sg&a per share of $5.10 is higher than 85% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 8 consecutive years, from $0.29 in FY2017 to $5.10 in FY2025.
Based on SEC 10-K filings.
5.10 in FY2025 with a 5-year CAGR of +44.8%. Top quartile in the Health Care sector.
Increased from $3.82 to $5.10 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +18.7%
- 5-Year CAGR
- +44.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 210This company $5.10 Sector average $40.75
▼
-87.5% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s sg&a per share has grown for 8 consecutive years.
- In FY2025, sg&a per share increased 26.6% year-over-year.
- Ranks #32 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.10 | +26.6% |
| FY2024 | $4.02 | +5.5% |
| FY2023 | $3.82 | +25.1% |
| FY2022 | $3.05 | +67.6% |
| FY2021 | $1.82 | +127.0% |
| FY2020 | $0.80 | +97.2% |
| FY2019 | $0.41 | +9.6% |
| FY2018 | $0.37 | +27.1% |
| FY2017 | $0.29 | -36.3% |
| FY2016 | $0.46 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026